1 / 7

New Products, New Paradigms: Combination Products for Women

New Products, New Paradigms: Combination Products for Women. Debra Birnkrant, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration Multipurpose Prevention Technologies Satellite AIDS 2012, Washington D.C. FDA Disclaimer.

virote
Télécharger la présentation

New Products, New Paradigms: Combination Products for Women

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. New Products, New Paradigms: Combination Products for Women Debra Birnkrant, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration Multipurpose Prevention Technologies Satellite AIDS 2012, Washington D.C.

  2. FDA Disclaimer The views in this presentation represent the author’s opinion and not necessarily official policy of the Food and Drug Administration

  3. Women and HIV Prevention • Recent exciting advances in the HIV prevention field • Proof-of-concept for vaginal microbicide tenofovir gel in CAPRISA 004 trial (2010) • Antiretroviral treatment prevents HIV-1 transmission observed in HPTN 052 trial (2011) • Approval of oral Truvada as pre-exposure prophylaxis or PrEP for reducing the risk of sexual acquisition of HIV-1 infection (2012)

  4. At a prevention crossroads of multiple sexual and reproductive women’s health issues Unintended pregnancy HIV acquisition Other sexually transmitted infections (STIs) Addressing Multiple Reproductive Health Needs HIV Prevention Preventing Unintended Pregnancy Preventing Other STIs

  5. Combining Multiple Preventive Products • Integrating products to address multiple reproductive health needs of women • Advantages • Convenient to use • Improves adherence • Broadens range of available options

  6. The Regulatory Pathway • Critical to demonstrate combination is safe and effective in preventing conditions or diseases • Formulating an appropriate regulatory approach to obtain data necessary for approval • Essential to review the data supporting the efficacy and safety claims

  7. Regulatory Collaboration • An effective MPT will be used by women worldwide • Collaborative regulatory efforts are important so developers can meet the requirements of national regulatory authorities

More Related